Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections
- PMID: 15075660
- PMCID: PMC1356241
- DOI: 10.1097/01.sla.0000114214.68169.e9
Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections
Abstract
Objective: To compare the clinical, microbiological, and therapeutic features of nonpostoperative nosocomial intra-abdominal infections (non-PostopNAI) with community-acquired intra-abdominal infections (CAI).
Summary background data: Prospective (June 2000 through January 2001) consecutive case series analysis of patients operated for secondary nonpostoperative intra-abdominal infections collected in 176 study centers (surgical wards and intensive care units).
Patients and methods: Clinical, microbiological, and therapeutic characteristics of CAI and non-PostopNAI infections were collected. Management of antibiotic therapy was decided by the attending physician. The efficacy of treatment was evaluated over a 30-day period after the index episode.
Results: Evaluatable observations (n = 1008) were collected (761 CAI and 247 non-PostopNAI), including 285 intensive care unit patients. When compared with CAI patients, non-PostopNAI patients presented an increased interval between admission to the surgical ward and operation (1.3 +/- 1.5 vs. 0.5 +/- 0.7 days in CAI patients; P < 0.001), increased proportions of underlying diseases, a more severe clinical condition as assessed by increased proportions of hospitalization in the intensive care unit (48% vs. 22% in CAI patients, P < 0.001) and a higher SAPS II score (34 +/- 15 vs. 24 +/- 14, P < 0.001). In non-PostopNAI patients, increased proportions of therapeutic failure (15% vs. 7% in CAI patients, P < 0.01) and of fatalities (12% vs. 4% in CAI patients, P < 0.001) were observed.
Conclusions: Delayed diagnosis and increased severity are the main characteristics of non-PostopNAI infections. Microbiological features are quite similar in CAI and non-PostopNAI infections, suggesting that antibiotic therapy recommended for CAI infections could be applied to non-PostopNAI patients. Characteristics of non-PostopNAI patients should lead to identify them as a specific entity in clinical trials.
Comment in
-
Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections.Ann Surg. 2004 Sep;240(3):560; author reply 560-1. doi: 10.1097/01.sla.0000138625.29700.24. Ann Surg. 2004. PMID: 15319731 Free PMC article. No abstract available.
References
-
- Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis: Mosby; 1996:A-1–A-20.
-
- Carlet J, Goldstein FW, Bleriot JP, et al. Timentin in the antimicrobial treatment of nosocomial and polymicrobial infections. J Antimicrob Chemother. 1986;17:149–159. - PubMed
-
- Schoeffel U, Jacobs E, Ruf G, et al. Intraperitoneal micro-organisms and the severity of peritonitis. Eur J Surg. 1995;161:501–508. - PubMed
-
- Sawyer RG, Rosenlof LK, Adams RB, et al. Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg. 1992;58:82–87. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
